Eisai presentations at the Annual Meeting of the American Epilepsy Society (AES) included key data on long-term convulsive seizure-freedom rates of adjunctive perampanel (marketed as FYCOMPAŽ CIII) in adolescent patients, monotherapy in partial-onset seizures and healthcare utilization associated with perampanel therapy

Thursday, December 7, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

- About 31% of patients with secondarily generalized (SG) and 50% of those with primarily generalized tonic-clonic (PGTC) seizures experienced convulsive seizure-freedom at year three in open-label extension study in adolescents



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store